Document is current
Any future updates will be listed below
-
Authors
Sherif, Shimaa
Mall, Raghvendra
Almeer, Hossam
Naik, Adviti
Al Homaid, Abdulaziz
Thomas, Remy
Roelands, Jessica
Narayanan, Sathiya
Mohamed, Mahmoud Gasim
Bedri, Shahinaz
Al-Bader, Salha Bujassoum
Junejo, Kulsoom
Bedognetti, Davide
Hendrickx, Wouter
Decock, Julie https://orcid.org/0000-0002-4409-100X
-
Funding
Funding for this research was provided by:
Qatar Biomedical Research Institute, Hamad Bin Khalifa University (VR80)
Qatar National Research Fund (JSREP07-010-3-005)
- License Information
-
More Information
Article History
Received: 16 July 2022
Accepted: 19 September 2022
First Online: 30 September 2022
Declarations
:
: The study on the RAQA cohort was approved by the local ethical committees of the Hamad Medical Corporation (study approval number #14027/14), the Qatar Biomedical Research Institute (study approval number #2016-002), and Sidra Medicine (study approval number #1711015664), and was performed following the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study protocol was granted a waiver of informed consent under the condition of anonymization and the absence of additional interventions.
: Not applicable.
: The authors declare that they have no competing interests.
